CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC

NCT05774899 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Adenoid Cystic Carcinoma
Metastatic Adenoid Cystic Carcinoma
Recurrent Adenoid Cystic Carcinoma

Interventions

DRUG: CB-103
DRUG: Abemaciclib
DRUG: Lenvatinib

Sponsor

Glenn J. Hanna

Collaborators

[object Object]
[object Object]